FNY Partners Fund’s Bristol-Myers Squibb BMY Stock Holding History

FNY Partners Fund’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-35	Closed	-$1K	–	574
2017 Q2	$1K	Buy	+35	New	+$1.91K	﹤0.01%	493

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

FNY Partners Fund's BMY Position: Q4 2017 in Review

FNY Partners Fund sold out of Bristol-Myers Squibb (BMY) in Q4 2017, closing a stake of 500 shares — an estimated $31K sold.

FNY Partners Fund first reported a position in BMY in Q4 2016 and held it in 2 quarters. The position peaked at $58K in Q4 2016. 1,736 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

FNY Partners Fund reported no remaining Bristol-Myers Squibb position as of Q4 2017 after selling out during the quarter.
FNY Partners Fund sold 500 Bristol-Myers Squibb shares in Q4 2017, an estimated $31K.
FNY Partners Fund first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 2 quarters.
FNY Partners Fund's Bristol-Myers Squibb position peaked at $58K in Q4 2016.
1,736 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on FNY Partners Fund's 13F filing for Q4 2017, filed 24 Jan 2018.